Difficulty: Medium
Average Score: 77%
Practice
A 55-year-old man complains of poor urinary flow and nocturia. He is found to suffer from benign prostatic hyperplasia. The physician prescribes finasteride to help his symptoms. What is the mechanism of action of this agent?
Correct answer
C
Rationale
The correct answer is C) Inhibits 5-╬▒-reductase.
Explanation:
Finasteride is a 5-╬▒-reductase inhibitor, which means it works by blocking the enzyme 5-╬▒-reductase. This enzyme is responsible for converting testosterone into dihydrotestosterone (DHT), a more potent form of testosterone. In benign prostatic hyperplasia (BPH), the prostate gland enlarges due to the actions of DHT. By inhibiting 5-╬▒-reductase, finasteride reduces the levels of DHT, leading to shrinkage of the prostate gland and improvement in urinary symptoms.
Why the other options are wrong:
A) Antagonizes ╬▒Ôéü-adrenergic receptors: This mechanism is seen in alpha-blockers like tamsulosin, which are used to treat BPH but not the action of finasteride.
B) Blocks DHT receptors: Finasteride does not block DHT receptors but inhibits the production of DHT.
D) Inhibits testosterone synthesis: Finasteride specifically targets the conversion of testosterone to DHT by inhibiting 5-╬▒-reductase, rather than inhibiting overall testosterone synthesis.
Educational context:
Understanding the mechanism of action of pharmacological agents like finasteride is crucial for nursing students and healthcare professionals to provide safe and effective care to patients with BPH. By knowing how finasteride works, healthcare providers can educate patients on the expected outcomes of treatment and monitor for potential side effects. This knowledge also helps in making informed decisions regarding medication selection and management of BPH.
Explanation:
Finasteride is a 5-╬▒-reductase inhibitor, which means it works by blocking the enzyme 5-╬▒-reductase. This enzyme is responsible for converting testosterone into dihydrotestosterone (DHT), a more potent form of testosterone. In benign prostatic hyperplasia (BPH), the prostate gland enlarges due to the actions of DHT. By inhibiting 5-╬▒-reductase, finasteride reduces the levels of DHT, leading to shrinkage of the prostate gland and improvement in urinary symptoms.
Why the other options are wrong:
A) Antagonizes ╬▒Ôéü-adrenergic receptors: This mechanism is seen in alpha-blockers like tamsulosin, which are used to treat BPH but not the action of finasteride.
B) Blocks DHT receptors: Finasteride does not block DHT receptors but inhibits the production of DHT.
D) Inhibits testosterone synthesis: Finasteride specifically targets the conversion of testosterone to DHT by inhibiting 5-╬▒-reductase, rather than inhibiting overall testosterone synthesis.
Educational context:
Understanding the mechanism of action of pharmacological agents like finasteride is crucial for nursing students and healthcare professionals to provide safe and effective care to patients with BPH. By knowing how finasteride works, healthcare providers can educate patients on the expected outcomes of treatment and monitor for potential side effects. This knowledge also helps in making informed decisions regarding medication selection and management of BPH.